Prognostic impact and concordance of TERT promoter mutation and protein expression in matched primary and metastatic cutaneous melanoma

被引：0
|
作者：
Emilia Hugdahl
May Britt Kalvenes
Monica Mannelqvist
Rita G Ladstein
Lars A Akslen
机构：
[1] Centre for Cancer Biomarkers CCBIO,Department of Clinical Medicine
[2] University of Bergen,Department of Dermatology
[3] Haukeland University Hospital,Department of Pathology
[4] Haukeland University Hospital,undefined
来源：
British Journal of Cancer | 2018年 / 118卷
关键词：
nodular melanoma; metastases; promoter mutation; TERT protein expression; prognosis; inter-tumoural discordance; intra-tumoural discordance;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：98 / 105
页数：7
相关论文
共 50 条
  • [41] Expression of Melan-A/MART-1 antigen as a prognostic factor in primary cutaneous melanoma
    Cerottini, J
    Berset, M
    Rimoldi, D
    Guggisberg, D
    Romero, P
    Burri, F
    Panizzon, R
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2001, 117 (02) : 468 - 468
  • [42] Prospective validation of the prognostic 31-gene expression profiling test in primary cutaneous melanoma
    Keller, Jennifer
    Schwartz, Theresa L.
    Lizalek, Jason M.
    Chang, Ea-sle
    Patel, Ashaki D.
    Hurley, Maria Y.
    Hsueh, Eddy C.
    CANCER MEDICINE, 2019, 8 (05): : 2205 - 2212
  • [43] Expression of Melan-A/MART-1 antigen as a prognostic reactor in primary cutaneous melanoma
    Berset, M
    Cerottini, JP
    Guggisberg, D
    Romero, P
    Burri, F
    Rimoldi, D
    Panizzon, RG
    INTERNATIONAL JOURNAL OF CANCER, 2001, 95 (01) : 73 - 77
  • [44] A comparison of expression profiles of 588 human genes for a primary uveal melanoma and cultured metastatic cutaneous melanoma cells.
    Hovland, PG
    Hovland, KR
    Hovland, AN
    Prasad, KN
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2000, 41 (04) : S381 - S381
  • [45] Folate receptor expression prevalence across multiple tumor types and concordance between matched primary and metastatic tumor pairs
    Li, Hewei
    Wu, Qiuyan
    Xing, Guan
    Teslenko, Vic
    Van Tornout, Jan
    Ahlers, Christoph M.
    Huang, Fei
    CANCER RESEARCH, 2010, 70
  • [46] Clinical and prognostic significance of BRAF V600E mutation in non-metastatic cutaneous melanoma patients
    Tas, F.
    Erturk, K.
    NEOPLASMA, 2019, 66 (04) : 631 - 636
  • [47] P53 EXPRESSION IN CUTANEOUS MALIGNANT-MELANOMA - AN IMMUNOHISTOCHEMICAL STUDY OF 87 CASES OF PRIMARY, RECURRENT, AND METASTATIC MELANOMA
    BARNHILL, RL
    CASTRESANA, JS
    RUBIO, MP
    MARTIN, MT
    IDOATE, M
    VAZQUEZ, JJ
    THOR, AD
    MODERN PATHOLOGY, 1994, 7 (05) : 533 - 535
  • [48] The place and prognostic value of TERT promoter mutation in molecular classification in grade II-III glial tumours and primary glioblastomas
    Terzi, N. Kaya
    Yilmaz, I.
    Oz, A. B.
    VIRCHOWS ARCHIV, 2019, 475 : S32 - S33
  • [49] The Place and Prognostic Value of TERT Promoter Mutation in Molecular Classification in Grade II-III Glial Tumors and Primary Glioblastomas
    Terzi, Neslihan Kaya
    Yilmaz, Ismail
    Oz, Aysim Buge
    TURKISH JOURNAL OF PATHOLOGY, 2022, 38 (02) : 90 - 98
  • [50] Heat shock protein 70 membrane expression and melanoma-associated marker phenotype in primary and metastatic melanoma
    Farkas, B
    Hantschel, M
    Magyarlaki, M
    Becker, B
    Scherer, K
    Landthaler, M
    Pfister, K
    Gehrmann, M
    Gross, C
    Mackensen, A
    Multhoff, G
    MELANOMA RESEARCH, 2003, 13 (02) : 147 - 152
12345